De-identified human iPSC lines YH10, BJ4, and 1323–2 were obtained from Dr Bruce Conklin (Gladstone Institutes, described previously in [27 (link)]). The H1 ESCs were obtained from Dr Paul Tesar (Case Western Reserve University). Human ESCs and iPSCs were used between passages 20–40, maintained in xeno-free conditions in E8 medium on Vitronectin-coated (Life Technologies) plates, and passaged every 3–5 days to prevent differentiation. Unless otherwise specified, reagents were purchased from Gibco.
Free full text: Click here